Skip Ribbon Commands
Skip to main content
 
Publications
Since 1974, the use of EBMT data and statistical resources have resulted in more than 600 publications in peer-reviewed scientific journals. 
 
Please click on this document to download the Authorship guidelines for EBMT publications
 

Use the various filters on the table to sort the publications by year, WP, publication title, 1st listed author, journal, PMID.

 
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
  
  
  
  
  
  
2017CMWPHigh dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.Cook GHaematologica.27634201
2017ALWPImproving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Giebel SHaematologica27686376
2017IEWPUse of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation.Yeates LBone Marrow Transplant.28092354
2016IEWPA prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis.Speckmann CJ Allergy Clin Immunol.27658761
2016CMWPAllogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.Robin MBone Marrow Transplant.27819688
2016CMWPAllogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party.Sobh MLeukemia27118410
2016CMWPAllogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT.Heidenreich SBiol Blood Marrow Transplant.27720995
2016CMWPAntilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.Kröger NN Engl J Med.26735993
2016PDWPAssociation of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation.Huezo-Diaz Curtis PPharmacogenomics J.27779248
2016ALWPAssociation of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.Giebel SOncologist. 26869584
2016ALWPAutologous transplant remains the preferred therapy for relapsed APL in CR2.Ganzel CBone Marrow Transplant. 27088379
2016CMWPComparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the EuropPotter VTBiol Blood Marrow Transplant.27264633
2016CQLWPDevelopment, preliminary usability and accuracy testing of the EBMT 'eGVHD App' to support GvHD assessment according to NIH criteria-a proof of concept.Schoemans HBone Marrow Transplant. 27042834
2016ADWPDoes ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?Oliveira MCBone Marrow Transplant.26642332
2016EBMTECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.Maertens JJ Antimicrob Chemother.27550992
2016EBMTECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.Alanio AJ Antimicrob Chemother.27550991
2016EBMTECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.Maschmeyer GJ Antimicrob Chemother. 27550993
2016EBMTEconomics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.Gratwohl AEBioMedicine. 26844291
2016ALWPExpanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.Savani BNHaematologica26969081
2016ADWPHaematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.Kelsey PJCurr Res Transl Med.27316390
2016EBMT Activity Survey OfficeHematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.Passweg JRBone Marrow Transplant.26901709
2016EBMTHemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.Baronciani DBone Marrow Transplant.26752139
2016ALWPHigh CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelateCzerw TOncotarget.27036034
2016STWPHigh-dose chemotherapy and autologous hematopoietic stem cell transplantation as adjuvant treatment in high-risk breast cancer: data from the EBMT registry.Martino MBiol Blood Marrow Transplant. 26723932
2016ALWPImpact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.Rubio MTJ Hematol Oncol. 26980295
2016PDWPImpact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow TransplantaLucchini GBiol Blood Marrow Transplant.27916512
2016CTIWPImpact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis.Saccardi RTransfusion27245270
2016ALWP / IDWPImpact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the EuropStyczynski JJ Clin Oncol.27091716
2016EBMTImpact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).Passweg JRBone Marrow Transplant.27819687
2016PDWPIncidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.Bresters DBone Marrow Transplant.27348540
1 - 30Next